Daniel Karlin

Chief Medical Officer

Daniel Karlin (Chief Medical Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Definium Therapeutics, Inc. (DFTX). The largest single filing was $452K of DFTX (10,035 sh × $45.03, as filed), executed Jun 25.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$600K

shares × price, as filed

Last traded

Jun 25

Filed Jun 26

Median ADV $136.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $600K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

DFTX Definium Therapeutics, Inc. DFTX · 0 buys · 2 sells 2 filings

Recent filings

DFTXSALE Definium Therapeutics, Inc. View filing → $452K
10,035 sh × $45.03
Exec Jun 25
Filed Jun 26 · 5:30 PM ET DFTXSALE Definium Therapeutics, Inc. View filing → $148K
8,018 sh × $18.47
Exec Mar 25
Filed Mar 26 · 5:30 PM ET